Benjamin Jackson Sells Shares of SERA

Benjamin Jackson, General Counsel at SERA, sold 2,179 shares of the company on June 11, 2026. The shares were sold at an average price of $2.01, totaling $4,379.79. This transaction was not part of a pre-planned trading program.

Other Institutional Activity in SERA

BAKER BROS. ADVISORS LP maintained its position in SERA with 5,498,170 shares valued at approximately $11.16 million. WHETSTONE CAPITAL ADVISORS, LLC trimmed its holdings by 152,824 shares, bringing its total to 3,306,889 shares worth about $6.71 million. ABERDEEN GROUP PLC increased its stake by 271,076 shares, ending with 2,550,775 shares valued at around $5.18 million. Meanwhile, PSP RESEARCH LLC and VANGUARD CAPITAL MANAGEMENT LLC both initiated new positions, each holding 2,396,685 and 1,204,115 shares, respectively.

SERA Stock Snapshot

Shares of SERA traded at approximately $1.905. The stock's recent trading activity involves a range of institutional movements, reflecting varying levels of confidence and strategy among investors.

Insider Buying and Selling at Sera Prognostics, Inc.

On June 11, 2026, several SERA executives reported selling shares. Chief Medical Officer Tiffany Inglis sold 362 shares, CEO Zhenya Lindgardt sold 6,990 shares, CFO Austin Aerts sold two separate lots of 2,037 and 5,440 shares, and Chief Commercial Officer Dyaarl Lee Jr. sold 4,739 shares, all at $2.01 per share. These transactions were not part of planned trading programs.

Analysts Set New Price Targets

On June 4, 2026, Craig-Hallum initiated coverage of SERA with a buy rating and set a price target of $6.00. Earlier, on March 23, 2023, Citigroup maintained its hold rating with a price target of $4.25. The consensus among analysts is mixed, with a range of ratings reflecting varied outlooks on SERA's potential.

About SERA

SERA operates in the [industry sector] and is involved in [describe core business activities]. The company is headquartered in [location] and led by CEO Zhenya Lindgardt. SERA's business strategy focuses on [key focus areas].

Bottom Line

Insider activity at SERA, including the sale by Benjamin Jackson, provides insights into the company's internal sentiment. The recent analyst coverage by Craig-Hallum adds a positive outlook with a buy rating. Investors often watch these insider transactions and analyst ratings to gauge the company's potential future performance.